Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005
Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005
Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurol 64:353-355, Limdi, N.A., et al, 2005
Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005
Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005
Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005
Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005
Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005
Levodopa Addiction in Idiopathic Parkinson Disease
Neurol 65:1508, Borek,L.L &Friedman,J.H., 2005
Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005
Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005
Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005
Unusual Presentation of Central Nervous System Cryptococcal Infection in an Immunocompetent Patient
AJNR 26:2522-2526, Saigal,G.,et al, 2005
Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Intra-Arterial Thrombolysis of Complete Deep Cerebral Venous Thrombosis
Neurol 63:2444-2445, Liebetrau,M.,et al, 2004
Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
NEJM 351:2170-2178, Alexandrov,A.V.,et al, 2004
Rheolytic Catheter Thrombectomy, Balloon Angioplasty, and Direct Recombinant Tissue Plasminogen Activator Thrombolysis of Dural Sinus Thrombosis with Preexisting Hemorrhagic Infarctions
AJNR 25:1807-1811, Curtin,K.R.,et al, 2004
Access to Intra-Arterial Therapies for Acute Ischemic Stroke: An Analysis of the US Population
AJNR 25:1802-1806, Suzuki,S.,et al, 2004
Thrombolysis for Acute Ischemic Stroke
Stroke 35:2914-2915, Wardlaw,J.,et al, 2004
Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004
Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004
Recreational Use of Phenytoin, Marijuana, and Alcohol: A Case Report
Neurol 62:2330, Jessen,K., 2004
Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004
Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004
Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004
Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004
Multi-Section CT Angiography for Detection of Cerebral Aneurysms
AJNR 25:1485-1492, Teksam,M.,et al, 2004
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004
Rapid Infusion with Valproate Sodium is Well Tolerated in Patients with Epilepsy
Neurol 63:1507-1508, Wheless,J.W.,et al, 2004
Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Daily Scheduled Opioids for Intractable Head Pain
Neurol 62:1687-1694,1662, Saper,J.R.,et al, 2004
Intravenous r-TPA in Vertebrobasilar Acute Infarcts
Neurol 62:1854-1856, Montavont,A.,et al, 2004
Clinical and Radiological Predictors of Recanalisation and Outcome of 40 Patients with acute Basilar Artery Occlusion Treated with Intra-Arterial Thrombolysis
JNNP 75:857-862, Arnold,M.,et al, 2004